Bellinda A. Bladergroen

Author

Utrecht University

Also Known As

Bellinda A Bladergroen, Bellinda A. BLADERGROEN, Bellinda A. Bladergroen, Bellinda A. Bladergroen

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Utrecht University Amsterdam UMC Location Vrije Universiteit Amsterdam University Medical Center Utrecht Sanquin Radboud University Medical Center

About

Bellinda A. Bladergroen is an author at Utrecht University specializing in medicine, cell biology, and cell signaling.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	472
2	Natural Sciences	2	2	57
3	Allergy	2	2	239
4	Biochemistry	2	2	57
5	Health Sciences	1	1	21

Bellinda A. Bladergroen

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Expression of the Serpin Serine Protease Inhibitor 6 Protects Dendritic Cells from Cytotoxic T Lymphocyte–Induced Apoptosis Jan Paul Medema, Danita H. Schuurhuis, Delphine Réa, The Journal of Experimental Medicine ApoptosisImmunologyProtects Dendritic CellsCell DeathImmunologic Mechanism	2001	205
Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system? Bellinda A. Bladergroen, Chris J.L.M. Meijer, Rosita L. ten Berge, Blood	2002	153
The Granzyme B Inhibitor, Protease Inhibitor 9, Is Mainly Expressed by Dendritic Cells and at Immune-Privileged Sites Bellinda A. Bladergroen, Merel C. M. Strik, Niels Bovenschen, The Journal of Immunology	2001	152
Expression levels of apoptosis-related proteins predict clinical outcome in anaplastic large cell lymphoma Rosita L. ten Berge, Chris J.L.M. Meijer, Danny F. Dukers, Blood	2002	121
Human mast cells produce and release the cytotoxic lymphocyte associated protease granzyme B upon activation Merel C. M. Strik, Pieter J.A. de Koning, Monique J. Kleijmeer, Molecular Immunology Autoimmune DiseaseProtease Granzyme BGranulocyteImmune Cell DevelopmentMast Cell Disorder	2007	111
Expression of the Apoptosis Inhibitor Protease Inhibitor 9 Predicts Clinical Outcome in Vaccinated Patients with Stage III and IV Melanoma Inge S. van Houdt, Joost J. Oudejans, Alfonsus Johannes Maria van den Eertwegh, Clinical Cancer Research	2005	90
Monocyte Cell Surface Glycosaminoglycans Positively Modulate IL-4-Induced Differentiation toward Dendritic Cells Els den Dekker, Sander Grefte, Tonnie Huijs, The Journal of Immunology InflammationCytokineAutoimmune DiseaseInnate Immune SystemImmunology	2008	44
<i>In Vivo</i> Recruitment of Hematopoietic Cells Using Stromal Cell–Derived Factor 1 Alpha–Loaded Heparinized Three-Dimensional Collagen Scaffolds Bellinda A. Bladergroen, B. Siebum, Kim G.C. Siebers-Vermeulen, Tissue Engineering Part A	2008	43
Inhibition of phosphatidylcholine and phosphatidylethanolamine biosynthesis in rat‐2 fibroblasts by cell‐permeable ceramides Bellinda A. Bladergroen, Miguel Bussière, W. R. Klein, European Journal of Biochemistry Cell DeathCellular PharmacologyRadiolabelled CholineLipid MovementRadioactive Choline	1999	42
Intracellular serpin SERPINB6 (PI6) is abundantly expressed by human mast cells and forms complexes with β-tryptase monomers Merel C. M. Strik, Angela M. Wolbink, Dorine Wouters, Blood	2003	40

Page 1